medigraphic.com

2011, Number 3

<< Back Next >>

Rev Med MD 2011; 2.3 (3)

Metabolic surgery

Prieto-Aldape MR, Aceves-Ávalos M, Martínez-Medrano A, Anaya-Prado R, Aceves-Velázquez E

Language: Spanish
References: 41
Page: 155-161
PDF size: 573.50 Kb.


ABSTRACT

Obesity surgery or "bariatric" surgery has matured in an unimaginable way, from the early gastrointestinal procedures, certainly aggressive, with the sole purpose of weight reduction, explained by mechanical processes (restriction / malabsorption) to sophisticated “metabolic” procedures that have not only demonstrated to effectively reduce the excess of weight in the long term, but surprisingly also achieve improvement and even resolution of diseases previously reserved for clinicians. With the above has become fashionable the term "metabolic surgery" that certainly is nothing new. In this paper we present the current status of gastrointestinal procedures for reducing excess of weight and improvement or resolution of obesity-related diseases, which are unfairly called "bariatric." The mechanisms by which these metabolic changes occur have not been clarified, but there are possible paths that delineate the machinery that leads to the homeostasis of insulin and blood sugar levels. With the new findings from conventional procedures and the novel procedures (in research) a new point of view has become to one of the diseases that most generate morbidity and mortality in the world, diabetes mellitus. Surgery "bariatric" or "metabolic" and even called "diabetes surgery" leaves open the possibility for millions of people around the world, obese and possibly non-obese the resolution of this disease and its serious consequences.


REFERENCES

  1. Buchwald H. Metabolic Surgery. New York, Ny: Grune and Stratton, 1978.

  2. Stanley Leonard Robbins V.K., Abul K.A., Fausto N., Pekins J.A. Robbins y Cotran: patología estructural y funcional: Elsevier España, 2008.

  3. Olaiz-Fernández G. Encuesta Nacional de Salud y Nutrición 2006. Instituto Nacional de Salud Pública 2006.

  4. Standards of medical care in diabetes--2009. Diabetes Care 2009; 32 Suppl 1:S13-61.

  5. 5.Friedman M.N., Sancetta A.J., Magovern G.J. The amelioration of diabetes mellitus following subtotal gastrectomy. Surg Gynecol Obstet 1955; 100(2):201- 4.

  6. Forgacs S., Halmos T. Improvement of glucose tolerance in diabetics following gastrectomy. Z Gastroenterol 1973; 11(4):293-6.

  7. 7.Halverson J.D., Kramer J., Cave A., et al. Altered glucose tolerance, insulin response, and insulin sensitivity after massive weight reduction subsequent to gastric bypass. Surgery 1982; 92(2):235-40.

  8. 8.Schrumpf E., Bergan A., Djoseland O., et al. The effect of gastric bypass operation on glucose tolerance in obesity. Scand J Gastroenterol Suppl 1985; 107:24-31.

  9. Pories W.J., Swanson M.S., MacDonald K.G., et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222(3):339-50; discussion 350-2.

  10. Hickey M.S., Pories W.J., MacDonald K.G. Jr., et al. A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? Ann Surg 1998; 227(5):637-43; discussion 643-4.

  11. Ballantyne G.H., Gumbs A., Modlin I.M. Changes in insulin resistance following bariatric surgery and the adipoinsular axis: role of the adipocytokines, leptin, adiponectin and resistin. Obes Surg 2005; 15(5):692-9.

  12. 12.Gumbs A.A., Modlin I.M., Ballantyne G.H. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss. Obes Surg 2005; 15(4):462-73.

  13. 13.Thaler J.P., Cummings D.E. Minireview: Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 2009; 150(6):2518-25.

  14. 14.Schauer P.R., Burguera B., Ikramuddin S., et al. Effect of laparoscopic Rouxen Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003; 238(4):467-84; discussion 84-5.

  15. Rubino F., Forgione A., Cummings D.E., et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg 2006; 244(5):741-9.

  16. 16.Rubino F., Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 2004; 239(1):1-11.

  17. 17.Folli F., Pontiroli A.E., Schwesinger W.H. Metabolic aspects of bariatric surgery. Med Clin North Am 2007; 91(3):393-414, x.

  18. Nakazato M., Murakami N., Date Y., et al. A role for ghrelin in the central regulation of feeding. Nature 2001; 409(6817):194-8.

  19. 19.Mason E.E. Vertical banded gastroplasty for obesity. Arch Surg 1982; 117(5):701-6.

  20. 20.Kuzmak L.I. A Review of Seven Years' Experience with Silicone Gastric Banding. Obes Surg 1991; 1(4):403-408.

  21. 21.Mason E.E., Ito C. Gastric bypass in obesity. Surg Clin North Am 1967; 47(6):1345-51.

  22. Scopinaro N., Gianetta E., Civalleri D., et al. Bilio-pancreatic bypass for obesity: II. Initial experience in man. Br J Surg 1979; 66(9):618-20.

  23. Marceau P., Hould F.S., Simard S., et al. Biliopancreatic diversion with duodenal switch. World J Surg 1998; 22(9):947-54.

  24. 24.Cohen R.V., Schiavon C.A., Pinheiro J.S., et al. Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22-34 2 kg/m : a report of 2 cases. Surg Obes Relat Dis 2007; 3(2):195-7.

  25. Deitel M., Crosby R.D., Gagner M. The First International Consensus Summit for Sleeve Gastrectomy (SG), New York City, October 25-27, 2007. Obes Surg 2008; 18(5):487-96.

  26. de Paula A.L., Macedo A.L., Prudente A.S., et al. Laparoscopic sleeve gastrectomy with ileal interposition ("neuroendocrine brake")--pilot study of a new operation. Surg Obes Relat Dis 2006; 2(4):464-7.

  27. Rodriguez-Grunert L., Galvao-Neto M.P., Alamo M., et al. First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve. Surg Obes Relat Dis 2008; 4(1):55-9.

  28. Scopinaro N., Marinari G.M., Camerini G.B., et al. Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: a long-term follow-up study. Diabetes Care 2005; 28(10):2406-11.

  29. Vidal J., Ibarzabal A., Romero F., et al. Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg 2008; 18(9):1077-82.

  30. Buchwald H., Avidor Y., Braunwald E., et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292(14):1724-37.

  31. Buchwald H., Estok R., Fahrbach K., et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122(3):248-256 e5.

  32. Mistry S.B., Omana J.J., Kini S. Rat models for bariatric surgery and surgery for type 2 diabetes mellitus. Obes Surg 2009; 19(5):655-60.

  33. Rubino F., Zizzari P., Tomasetto C., et al. The role of the small bowel in the regulation of circulating ghrelin levels and food intake in the obese Zucker rat. Endocrinology 2005; 146(4):1745-51.

  34. Pacheco D., de Luis D.A., Romero A., et al. The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats. Am J Surg 2007; 194(2):221-4.

  35. Wang T.T., Hu S.Y., Gao H.D., et al. Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1. Ann Surg 2008; 247(6):968-75.

  36. Dixon J.B., O'Brien P.E., Playfair J., et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. Jama 2008; 299(3):316-23.

  37. 37.Lee W.J., Wang W., Lee Y.C., et al. Effect of laparoscopic mini-gastric bypass 2 for type 2 diabetes mellitus: comparison of BMI>35 and <35 kg/m . J Gastrointest Surg 2008; 12(5):945-52.

  38. 38.Scopinaro N., Papadia F., Marinari G., et al. Long-term control of type 2 diabetes mellitus and the other major components of the metabolic syndrome 2 after biliopancreatic diversion in patients with BMI < 35 kg/m . Obes Surg 2007; 17(2):185-92.

  39. 39.Fried M., Ribaric G., Buchwald J.N, et al. Metabolic Surgery for the 2 Treatment of Type 2 Diabetes in Patients with BMI <35 kg/m : An Integrative Review of Early Studies. Obes Surg 2010.

  40. 40.Naik R.G., Brooks-Worrell B.M., Palmer J.P. Latent autoimmune diabetes in adults. J Clin Endocrinol Metab 2009; 94(12):4635-44.

  41. Adams T.D., Gress R.E., Smith S.C., et al. Long-term mortality after gastric bypass surgery. N Engl J Med 2007; 357(8):753-61. Revista




2020     |     www.medigraphic.com